Current Trial - Enrolling
To evaluate the effects of ifetroban to improve sino-nasal symptoms in symptomatic AERD subjects.
- ≥18 years old
- Hx of asthma and nasal polyps
- At least 2 reactions to oral aspirin or dx of AERD in past 5 years by aspirin challenge
Clinical and Population Research